查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2158092

注射用氯胺酮市場：全球市場預測，2026-2032年

Injectable Ketamine Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，注射用氯胺酮市場規模將達到 11.6571 億美元，年複合成長率為 5.21%。

主要市場統計數據
基準年 2025 8.1657億美元
預計年份：2026年 8.6056億美元
預測年份 2032 1,165,710,000 美元
複合年成長率 (%) 5.21%

注射用氯胺酮：執行摘要及市場背景

注射用氯胺酮在臨床實務中用於麻醉、手術鎮靜、急性疼痛管理以及某些精神科治療。其提案在於起效迅速、具有分離性麻醉作用、鎮痛效果，且在常規治療無效時效用。其使用取決於適應症、患者選擇、臨床監督、產品品質以及相關法規。

在臨床實務中，使用方式正朝著基於方案、以安全為中心的方向轉變。

隨著人們對氯胺酮輔助治療的興趣日益濃厚，標準化劑量和監測的重要性日益凸顯，以及對仿單標示外用藥監管力度加大，整個醫療格局正在發生重塑。醫療機構正在加強知情同意程序、禁忌症篩檢、復健方案、記錄和追蹤。治療實踐的方向正從缺乏監管或定義模糊的治療模式轉向多學科管治。

人工智慧可輔助進行分診、監測和證據收集。

人工智慧可以輔助患者篩檢、臨床決策支援、不利事件檢測、記錄保存以及治療反應數據分析。負責任地使用人工智慧需要檢驗的資料集、可解釋的輸出結果、臨床醫生的監督、隱私保護以及明確的課責。在注射用氯胺酮的給藥過程中，人工智慧無法取代訓練有素的醫護人員、生理監測或緊急應變措施。

區域差異反映了法規、基礎設施和臨床能力。

在北美，儘管臨床基礎設施完善，且精神病學和疼痛管理領域的應用討論活躍，但對管製藥物的管控也十分關注。在歐洲，人們強調統一的品質標準，同時保留各國在處方和保險報銷上的差異。在亞太地區，先進的醫院系統與醫療服務取得和法律規範的多樣性並存。在拉丁美洲，專科醫生的能力和監測的可及性存在差異。在中東，專科服務在多元化的法規環境下發展，而在非洲，藥物的可近性、人力資源限制和醫院容量都會影響其應用。

跨區域趨勢：對安全的通用理解，以及獲取途徑的差異。

東南亞國協在監管成熟度、專家數量和醫院容量方面存在差異。金磚國家成員國在公共部門進入、國內製藥能力和臨床規範方面也存在顯著差異。歐盟藥品體系遵循通用原則，但各國具體實施方式不盡相同。七國集團（G7）國家普遍擁有先進的監測和研究基礎設施，而北約成員國的醫療保健體系則呈現出高度多樣化的特徵。海灣合作理事會（GCC）成員國正在投資建立專業醫療保健體系，但各成員國在管制藥品和精神科服務方面的監管規定存在差異。

各國分析揭示了監管和醫療服務途徑的差異。

澳洲、加拿大、法國、德國、義大利、日本、韓國、英國、英國和美國通常都已建立完善的麻醉服務和正規的藥物管制體系，但在批准的適應症、保險報銷和仿單標示外用藥的監管方面存在差異。巴西、墨西哥、印度、中國和俄羅斯的臨床需求龐大，但在醫療服務可近性、監管流程和專科醫療服務方面也存在區域差異。在這些國家，實施麻醉服務需要獲得許可的供應鏈、訓練有素的臨床醫生、監測設備、緊急應變計畫以及符合當地法規的文件記錄。

領導者應在擴大注射用氯胺酮服務之前建立管治結構。

產業領導者應針對每項適應症制定具體方案，認證用藥臨床醫生，並建立獨立的臨床管治。相關項目應包括系統性篩檢、知情同意、用藥依從性配對、持續生理監測、復健觀察、不利事件報告和長期追蹤。領導者還應評估供應鏈完整性、員工培訓、資料保護、轉診途徑以及當地管制藥品要求。證據產生應優先考慮具有臨床意義的結果、透明的報告以及對人工智慧工具的負責任評估。

調查方法：基於證據的臨床和營運狀況評估。

本執行摘要採用結構化的定性評估方法，從臨床適應症、監管、醫療服務、技術、基礎設施和地理條件等方面對注射氯胺酮進行了分析。該分析基於公開確立的麻醉安全、藥品管治、醫療能力和負責任的人工智慧應用原則，對目標區域、國家組和各國進行了比較。市場規模估算與預測、市場規模計算、市場佔有率、預測以及公司特定分析均未包含在內。

結論：負責任的整合是核心策略重點。

注射用氯胺酮的作用更取決於其使用相關的臨床管治質量，而非其藥理特性本身。永續的進展需要合適的患者選擇、訓練有素的團隊、可靠的藥物、標準化的監測、符合倫理的證據以及監管的協調一致。優先考慮安全性、課責和公平取得的機構將更有能力將注射用氯胺酮整合到適當的治療路徑中。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：注射用氯胺酮市場：依適應症分類

  • 麻醉
  • 疼痛管理
  • 創傷後壓力症候群（PTSD）
  • 難治性憂鬱症

第8章 注射用氯胺酮市場：依產品類型分類

  • esketamine
    • 品牌
    • 非專利的
  • 外消旋氯胺酮

第9章：注射用氯胺酮市場：依給藥途徑分類

  • 肌肉內注射
  • 靜脈輸液

第10章 注射用氯胺酮市場：依劑型分類

  • 預填充式注射器
  • 管瓶

第11章 注射用氯胺酮市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 門診部

第12章 注射用氯胺酮市場：依通路分類

  • 線上
  • 離線

第13章 注射用氯胺酮市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 注射用氯胺酮市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 注射用氯胺酮市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Anhui Wanhe Pharmaceutical Co., Ltd.
  • Aspen Pharmacare Holdings Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Farbe Firma Pvt. Ltd.
  • Fresenius Kabi AG
  • Gland Pharma Ltd.
  • Global Calcium Pvt. Ltd.
  • Hikma Pharmaceuticals PLC
  • Ipca Laboratories Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Johnson Matthey PLC
  • Mallinckrodt Pharmaceuticals Holdings, Inc.
  • Neon Laboratories Ltd.
  • Pfizer Inc.
  • Samarth Pharma Pvt. Ltd.
  • Sandoz International GmbH
  • Seqens SAS
  • Sun Pharmaceutical Industries Ltd.
  • Supriya Lifescience Ltd.
  • Swiss Parenterals Pvt. Ltd.
  • Taj Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Troikaa Parenterals Pvt. Ltd.
  • Umedica Laboratories Pvt. Ltd.
  • Verve Human Care Laboratories
  • Viatris Inc.

第18章 主要專家

Product Code: MRR-4654A89DA79B

The Injectable Ketamine Market is projected to grow by USD 1,165.71 million at a CAGR of 5.21% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 816.57 million
Estimated Year [2026] USD 860.56 million
Forecast Year [2032] USD 1,165.71 million
CAGR (%) 5.21%

Injectable Ketamine: Executive Summary and Market Context

Injectable ketamine is used in clinical settings for anesthesia, procedural sedation, acute pain management, and selected psychiatric applications. Its value proposition is linked to rapid onset, dissociative anesthesia, analgesic properties, and utility when conventional approaches are unsuitable. Use remains dependent on indication, patient selection, clinical supervision, product quality, and applicable regulation.

Clinical Practice Is Shifting Toward Protocolized, Safety-Centered Use

The landscape is being reshaped by broader interest in ketamine-assisted care, increasing emphasis on standardized dosing and monitoring, and greater scrutiny of off-label psychiatric use. Healthcare organizations are strengthening consent procedures, screening for contraindications, recovery protocols, documentation, and follow-up. The direction of practice is toward multidisciplinary governance rather than unsupervised or loosely defined treatment models.

Artificial Intelligence Supports Triage, Monitoring, and Evidence Development

Artificial intelligence can contribute to patient screening, clinical decision support, adverse-event detection, documentation, and analysis of treatment-response data. Its responsible use requires validated datasets, explainable outputs, clinician oversight, privacy safeguards, and clear accountability. AI does not replace trained personnel, physiologic monitoring, or emergency-readiness requirements during injectable ketamine administration.

Regional Differences Reflect Regulation, Infrastructure, and Clinical Capacity

North America has substantial clinical infrastructure and active discussion of psychiatric and pain applications, alongside strong attention to controlled-substance governance. Europe emphasizes harmonized quality standards while retaining country-level differences in prescribing and reimbursement. Asia-Pacific combines advanced hospital systems with varied access and regulatory frameworks. Latin America faces uneven specialist capacity and monitoring access. The Middle East is developing specialized services within diverse regulatory environments, while Africa's adoption is shaped by medicine availability, workforce constraints, and hospital capacity.

Cross-Group Patterns: Alignment on Safety, Variation in Access

ASEAN countries show differing levels of regulatory maturity, specialist availability, and hospital capability. BRICS members reflect wide variation in public-sector access, domestic pharmaceutical capacity, and clinical protocols. European Union systems operate within shared medicines principles but retain national implementation differences. G7 countries generally have advanced monitoring and research infrastructure, while NATO members span highly diverse healthcare systems. GCC countries are investing in specialized healthcare capacity, although rules governing controlled medicines and psychiatric services differ across members.

Country Insights Reveal Distinct Regulatory and Care Pathways

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally have established anesthesia services and formal medicine controls, but differ in accepted indications, reimbursement, and oversight of off-label care. Brazil, Mexico, India, China, and Russia combine significant clinical need with varied access, regulatory processes, and regional disparities in specialist services. Across these countries, implementation depends on licensed supply, trained clinicians, monitoring equipment, emergency protocols, and locally compliant documentation.

Leaders Should Build Governance Before Expanding Injectable Ketamine Services

Industry leaders should define indication-specific protocols, credential administering clinicians, and establish independent clinical governance. Programs should use structured screening, informed consent, medication reconciliation, continuous physiologic monitoring, recovery observation, adverse-event reporting, and longitudinal follow-up. Leaders should also assess supply-chain integrity, staff training, data protection, referral pathways, and local controlled-substance requirements. Evidence generation should prioritize clinically meaningful outcomes, transparent reporting, and responsible evaluation of AI-enabled tools.

Methodology: Evidence-Led Assessment of Clinical and Operating Conditions

This executive summary uses a structured qualitative assessment of injectable ketamine across clinical indications, regulation, care delivery, technology, infrastructure, and geographic conditions. The analysis compares the required regions, country groupings, and countries using publicly established principles of anesthesia safety, controlled-medicine governance, healthcare capacity, and responsible AI adoption. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis.

Conclusion: Responsible Integration Is the Central Strategic Priority

Injectable ketamine's role is shaped less by pharmacology alone than by the quality of clinical governance surrounding its use. Durable progress depends on appropriate patient selection, trained teams, reliable medicines, standardized monitoring, ethical evidence generation, and regulatory alignment. Organizations that treat safety, accountability, and equitable access as foundational will be better positioned to integrate injectable ketamine into appropriate care pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Injectable Ketamine Market, by Indication

  • 7.1. Introduction
  • 7.2. Anesthesia
  • 7.3. Pain Management
  • 7.4. Post-Traumatic Stress Disorder
  • 7.5. Treatment-Resistant Depression

8. Injectable Ketamine Market, by Product Type

  • 8.1. Introduction
  • 8.2. Esketamine
    • 8.2.1. Brand
    • 8.2.2. Generic
  • 8.3. Racemic Ketamine

9. Injectable Ketamine Market, by Route

  • 9.1. Introduction
  • 9.2. Intramuscular Injection
  • 9.3. Intravenous Infusion

10. Injectable Ketamine Market, by Formulation

  • 10.1. Introduction
  • 10.2. Prefilled Syringe
  • 10.3. Vial

11. Injectable Ketamine Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Center
  • 11.3. Hospital
  • 11.4. Outpatient Clinic

12. Injectable Ketamine Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Online
  • 12.3. Offline

13. Injectable Ketamine Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Injectable Ketamine Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Injectable Ketamine Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Anhui Wanhe Pharmaceutical Co., Ltd.
  • 17.2. Aspen Pharmacare Holdings Limited
  • 17.3. B. Braun Melsungen AG
  • 17.4. Baxter International Inc.
  • 17.5. Ciron Drugs & Pharmaceuticals Pvt. Ltd.
  • 17.6. Dr. Reddy's Laboratories Ltd.
  • 17.7. Farbe Firma Pvt. Ltd.
  • 17.8. Fresenius Kabi AG
  • 17.9. Gland Pharma Ltd.
  • 17.10. Global Calcium Pvt. Ltd.
  • 17.11. Hikma Pharmaceuticals PLC
  • 17.12. Ipca Laboratories Ltd.
  • 17.13. Jiangsu Hengrui Medicine Co., Ltd.
  • 17.14. Johnson Matthey PLC
  • 17.15. Mallinckrodt Pharmaceuticals Holdings, Inc.
  • 17.16. Neon Laboratories Ltd.
  • 17.17. Pfizer Inc.
  • 17.18. Samarth Pharma Pvt. Ltd.
  • 17.19. Sandoz International GmbH
  • 17.20. Seqens SAS
  • 17.21. Sun Pharmaceutical Industries Ltd.
  • 17.22. Supriya Lifescience Ltd.
  • 17.23. Swiss Parenterals Pvt. Ltd.
  • 17.24. Taj Pharmaceuticals Ltd.
  • 17.25. Teva Pharmaceutical Industries Ltd.
  • 17.26. Troikaa Parenterals Pvt. Ltd.
  • 17.27. Umedica Laboratories Pvt. Ltd.
  • 17.28. Verve Human Care Laboratories
  • 17.29. Viatris Inc.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Injectable Ketamine Market, Years Considered for the Study
  • FIGURE 2. Global Injectable Ketamine Market, Research Design
  • FIGURE 3. Global Injectable Ketamine Market, Research Framework
  • FIGURE 4. Global Injectable Ketamine Market, Data Triangulation
  • FIGURE 5. Global Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Injectable Ketamine Market Size, by Indication, 2025 vs 2032 (%)
  • FIGURE 7. Global Injectable Ketamine Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Injectable Ketamine Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Injectable Ketamine Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Injectable Ketamine Market Size, by Route, 2025 vs 2032 (%)
  • FIGURE 11. Global Injectable Ketamine Market Size, by Route, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Injectable Ketamine Market Size, by Formulation, 2025 vs 2032 (%)
  • FIGURE 13. Global Injectable Ketamine Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Injectable Ketamine Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Injectable Ketamine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Injectable Ketamine Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 17. Global Injectable Ketamine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Injectable Ketamine Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Injectable Ketamine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Injectable Ketamine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Injectable Ketamine Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Injectable Ketamine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Injectable Ketamine Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Injectable Ketamine Market Segmentation & Coverage
  • TABLE 2. Global Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 4. Global Anesthesia Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Anesthesia Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Anesthesia Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Pain Management Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Pain Management Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Pain Management Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Post-Traumatic Stress Disorder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Post-Traumatic Stress Disorder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Post-Traumatic Stress Disorder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Treatment-Resistant Depression Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Treatment-Resistant Depression Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Treatment-Resistant Depression Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 17. Global Esketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Esketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Esketamine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Brand Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Brand Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Brand Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Generic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Generic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Generic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Racemic Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Racemic Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Racemic Ketamine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 30. Global Intramuscular Injection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Intramuscular Injection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Intramuscular Injection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Intravenous Infusion Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Intravenous Infusion Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Intravenous Infusion Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 37. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Vial Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Vial Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Vial Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 44. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Outpatient Clinic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Outpatient Clinic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Outpatient Clinic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 54. Global Online Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Online Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Online Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Offline Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Offline Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Offline Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Asia-Pacific Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 69. North America Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 71. North America Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 72. North America Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 73. North America Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 74. North America Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 75. North America Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 76. North America Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 77. Latin America Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Latin America Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 79. Latin America Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 80. Latin America Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 81. Latin America Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 82. Latin America Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 83. Latin America Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 84. Latin America Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 85. Europe Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Europe Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 87. Europe Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 88. Europe Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 89. Europe Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 90. Europe Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 91. Europe Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 92. Europe Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 93. Middle East Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Middle East Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 95. Middle East Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 96. Middle East Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 97. Middle East Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 98. Middle East Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 99. Middle East Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 100. Middle East Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 101. Africa Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Africa Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 103. Africa Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 104. Africa Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 105. Africa Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 106. Africa Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 107. Africa Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 108. Africa Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 109. Global Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 112. ASEAN Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 113. ASEAN Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 114. ASEAN Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 115. ASEAN Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 116. ASEAN Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 117. ASEAN Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 118. GCC Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. GCC Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 120. GCC Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 121. GCC Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 122. GCC Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 123. GCC Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 124. GCC Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 125. GCC Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 126. European Union Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. European Union Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 128. European Union Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 129. European Union Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 130. European Union Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 131. European Union Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 132. European Union Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 133. European Union Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 134. BRICS Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. BRICS Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 136. BRICS Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 137. BRICS Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 138. BRICS Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 139. BRICS Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 140. BRICS Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 141. BRICS Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 142. G7 Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 143. G7 Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 144. G7 Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 145. G7 Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 146. G7 Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 147. G7 Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 148. G7 Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 149. G7 Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 150. NATO Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 151. NATO Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 152. NATO Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 153. NATO Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 154. NATO Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 155. NATO Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 156. NATO Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 157. NATO Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 158. Global Injectable Ketamine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 159. United States Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 160. United States Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 161. United States Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 162. United States Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 163. United States Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 164. United States Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 165. United States Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 166. United States Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 167. Canada Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 168. Canada Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 169. Canada Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 170. Canada Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 171. Canada Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 172. Canada Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 173. Canada Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 174. Canada Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 175. Mexico Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 176. Mexico Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 177. Mexico Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 178. Mexico Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 179. Mexico Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 180. Mexico Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 181. Mexico Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 182. Mexico Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. Brazil Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 184. Brazil Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 185. Brazil Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 186. Brazil Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 187. Brazil Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 188. Brazil Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 189. Brazil Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 190. Brazil Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 191. United Kingdom Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 192. United Kingdom Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 193. United Kingdom Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 194. United Kingdom Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 195. United Kingdom Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 196. United Kingdom Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 197. United Kingdom Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 198. United Kingdom Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 199. Germany Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 200. Germany Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 201. Germany Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 202. Germany Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 203. Germany Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 204. Germany Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 205. Germany Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 206. Germany Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 207. France Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 208. France Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 209. France Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 210. France Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 211. France Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 212. France Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 213. France Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 214. France Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 215. Russia Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 216. Russia Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 217. Russia Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 218. Russia Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 219. Russia Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 220. Russia Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 221. Russia Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 222. Russia Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 223. Italy Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 224. Italy Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 225. Italy Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 226. Italy Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 227. Italy Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 228. Italy Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 229. Italy Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 230. Italy Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 231. Spain Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 232. Spain Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 233. Spain Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 234. Spain Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 235. Spain Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 236. Spain Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 237. Spain Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 238. Spain Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 239. China Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 240. China Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 241. China Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 242. China Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 243. China Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 244. China Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 245. China Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 246. China Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 247. India Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 248. India Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 249. India Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 250. India Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 251. India Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 252. India Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 253. India Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 254. India Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 255. Japan Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 256. Japan Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 257. Japan Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 258. Japan Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 259. Japan Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 260. Japan Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 261. Japan Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 262. Japan Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 263. Australia Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 264. Australia Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 265. Australia Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 266. Australia Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 267. Australia Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 268. Australia Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 269. Australia Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 270. Australia Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 271. South Korea Injectable Ketamine Market Size, 2017-2032 (USD Million)
  • TABLE 272. South Korea Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 273. South Korea Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 274. South Korea Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
  • TABLE 275. South Korea Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
  • TABLE 276. South Korea Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 277. South Korea Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 278. South Korea Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 279. Global Injectable Ketamine Market Share, by Key Player, 2025
  • TABLE 280. Global Injectable Ketamine Market, Key Experts